Article Information
History
- April 8, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rocío Bravo-Jeria1,
- María Ximena Rojas Reyes2,
- Juan Víctor Ariel Franco3,
- María Paz Acuña4,5,
- Luz Ángela Torres López2,
- Gabriel Rada6,1,7,*,
- COVID-19 L·OVE Working Group
- 1UC Evidence Center, Cochrane Chile Associated Center, Pontificia Universidad Católica de Chile, Santiago, Chile
- 2Department of Research, Fundación Cardioinfantil, Bogotá, Colombia
- 3Department of Research, Instituto Universitario Hospital Italiano, Buenos Aires, Argentina
- 4Unidad de Infectología, Hospital Dr Sótero del Río, Santiago, Chile
- 5Unidad de Infectología, Hospital Clínico Dra Eloísa Díaz, La Florida, Santiago, Chile
- 6Fundación Epistemonikos, Santiago, Chile
- 7Internal Medicine Department, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
- ↵*Corresponding author:
Gabriel Rada, Email address: radagabriel{at}epistemonikos.org, Postal address: Holanda 895, Providencia, Santiago, Chile.
Posted April 08, 2020.
Chloroquine and hydroxychloroquine for the treatment of COVID-19: A living systematic review protocol
